Skip to main content

and
  1. Article

    Open Access

    Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer

    Despite the success of tamoxifen since its introduction, about one-third of patients with estrogen (ER) and/or progesterone receptor (PgR) - positive breast cancer (BC) do not benefit from therapy. Here, we ai...

    Henrik J Johansson, Betzabe C Sanchez, Jenny Forshed, Olle Stål in Clinical Proteomics (2015)

  2. Article

    Open Access

    Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer

    About one-third of oestrogen receptor alpha-positive breast cancer patients treated with tamoxifen relapse. Here we identify the nuclear receptor retinoic acid receptor alpha as a marker of tamoxifen resistanc...

    Henrik J. Johansson, Betzabe C. Sanchez, Filip Mundt in Nature Communications (2013)